EUVIMEDEUVIMED entdecken
Open Access · CC0

Long-term statin therapy is associated with severe coronary artery calcification

Kyari Sumayin Ngamdu, Dhairyasheel S Ghosalkar, Hojune E Chung, Jared L Christensen iD, Cadence Lee iD, Celia A Butler, Tiffany Ho, Alice Chu, Jacob R Heath, Muhammad Baig iD, Wen-Chih Wu, Gaurav Choudhary und 1 weitere

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0289111 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Kyari Sumayin Ngamdu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Research and Medicine, Vascular Research Laboratory, Providence VA Medical Center, Providence, Rhode Island, United States of America. Hauptthemen laut MEDLINE: Coronary Artery Disease, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Lung Neoplasms, Atherosclerosis. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: CSRD VA, BLRD VA, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Atherosclerosis and consequent risk of cardiovascular events or mortality can be accurately assessed by quantifying coronary artery calcium score (CACS) derived from computed tomography. HMG-CoA-reductase inhibitors (statins) are the primary pharmacotherapy used to reduce cardiovascular events, yet there is growing data that support statin use may increase coronary calcification. We set out to determine the likelihood of severe CACS in the context of chronic statin therapy.

Methods

We established a retrospective, case-control study of 1,181 U.S. veterans without coronary artery disease (CAD) from a single site, the Providence VA Medical Center. Duration of statin therapy for primary prevention was divided into 5-year categorical increments. The primary outcome was CACS derived from low-dose lung cancer screening computed tomography (LCSCT), stratified by CACs severity (none = 0; mild = 1–99; moderate = 100–399; and severe ≥400 AU). Statin duration of zero served as the referent control. Ordinal logistic regression analysis determined the association between duration of statin use and CACS categories. Proportional odds assumption was tested using likelihood ratio test. Atherosclerotic cardiovascular disease (ASCVD) risk score, body mass index, and CKD (glomerular filtration rate of 0–5 years, OR: 1.71 [CI: 1.34–2.18], p 5–10 years, OR: 2.80 [CI: 2.01–3.90], p 10 years, OR: 5.30 [CI: 3.23–8.70], p 0–5 years, OR: 1.49 [CI: 1.16–1.92], p = 0.002; >5–10 years, OR: 2.38 [CI: 1.7–3.35], p 10 years, OR: 4.48 [CI: 2.7–7.43], p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseaseHydroxymethylglutaryl-CoA Reductase InhibitorsLung NeoplasmsAtherosclerosisVascular CalcificationHumansMiddle AgedAgedRetrospective StudiesCase-Control StudiesEarly Detection of CancerCoronary AngiographyRisk FactorsRisk Assessment

Substanzen

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Departments of Research and Medicine, Vascular Research Laboratory, Providence VA Medical Center, Providence, Rhode Island, United States of America.
  • Department of Research, Ocean State Research Institute, Inc., Providence, Rhode Island, United States of America.
  • Department of Medicine, Section of Cardiology, Alpert Medical School of Brown University, Providence, Rhode Island, United States of America.

ORCID-Profile: Jared L Christensen, Cadence Lee, Muhammad Baig, Alan R Morrison

Förderung

  • CSRD VA
  • BLRD VA
  • NHLBI NIH HHS
  • VA VHA BLR&D
  • VA VHA CSR&D
  • National Heart, Lung, and Blood Institute of the National Institutes of Health
  • National Institute of General Medical Sciences of the National Institutes of Health

Zitieren

APA

Ngamdu, K. S., Ghosalkar, D. S., Chung, H. E., Christensen, J. L., Lee, C., Butler, C. A., Ho, T., Chu, A., Heath, J. R., Baig, M., Wu, W. C., Choudhary, G., & Morrison, A. R. (2023). Long-term statin therapy is associated with severe coronary artery calcification. PLOS ONE. https://doi.org/10.1371/journal.pone.0289111

Vancouver

Ngamdu KS, Ghosalkar DS, Chung HE, Christensen JL, Lee C, Butler CA, et al. Long-term statin therapy is associated with severe coronary artery calcification. PLOS ONE. 2023. doi:10.1371/journal.pone.0289111

BibTeX
@article{Ngamdu2023,
  author = {Ngamdu, Kyari Sumayin and Ghosalkar, Dhairyasheel S and Chung, Hojune E and Christensen, Jared L and Lee, Cadence and Butler, Celia A and Ho, Tiffany and Chu, Alice and Heath, Jacob R and Baig, Muhammad and Wu, Wen-Chih and Choudhary, Gaurav and Morrison, Alan R},
  title = {Long-term statin therapy is associated with severe coronary artery calcification},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0289111}
}
Kostenlos starten →